Celldex Therapeutics, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Celldex Therapeutics, Inc. stock issued during period, value, other for the quarter ending 2026-06-30 was $323.83M.
- Celldex Therapeutics, Inc. stock issued during period, value, other for the quarter ending 2024-03-31 was $432.30M.
- Celldex Therapeutics, Inc. stock issued during period, value, other for the quarter ending 2020-09-30 was $4.30M, a 74.46% increase year-over-year.
- Celldex Therapeutics, Inc. stock issued during period, value, other for the quarter ending 2020-06-30 was $23.69M, a 228.51% increase year-over-year.
- Celldex Therapeutics, Inc. stock issued during period, value, other for fiscal 2024 was $432.30M, a 99.93% increase from fiscal 2023.
- Celldex Therapeutics, Inc. stock issued during period, value, other for fiscal 2023 was $216.22M.
- Celldex Therapeutics, Inc. stock issued during period, value, other for fiscal 2020 was $29.43M, a 81.14% increase from fiscal 2019.
- Celldex Therapeutics, Inc. stock issued during period, value, other for fiscal 2019 was $16.25M, a 44.01% decline from fiscal 2018.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $323.83M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $432.30M 10-K · filed 2026-02-25 | |
| 2024-03-31 | $432.30M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $216.22M 10-K · filed 2026-02-25 | |
| 2020-12-31 | $29.43M 10-K · filed 2023-02-28 | |
| 2020-09-30 | $4.30M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $23.69M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $1.61M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $16.25M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $2.46M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $7.21M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $4.15M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $29.02M 10-K · filed 2021-03-29 | |
| 2018-09-30 | $5.49M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $8.27M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $11.69M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $51.02M 10-K · filed 2020-03-26 | |
| 2016-12-31 | $13.95M 10-K · filed 2019-03-07 | |
| 2013-12-31 | $17.13M 10-K/A · filed 2016-02-25 | |
| 2012-12-31 | $40.14M 10-K · filed 2015-02-24 | |
| 2011-12-31 | $2.15M 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |